<SEC-DOCUMENT>0001144204-17-010325.txt : 20170222
<SEC-HEADER>0001144204-17-010325.hdr.sgml : 20170222
<ACCEPTANCE-DATETIME>20170222115307
ACCESSION NUMBER:		0001144204-17-010325
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20170222
FILED AS OF DATE:		20170222
DATE AS OF CHANGE:		20170222

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Origin Agritech LTD
		CENTRAL INDEX KEY:			0001321851
		STANDARD INDUSTRIAL CLASSIFICATION:	AGRICULTURE PRODUCTION - CROPS [0100]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			D6
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-51576
		FILM NUMBER:		17627554

	BUSINESS ADDRESS:	
		STREET 1:		NO. 21 SHENG MING YUAN ROAD
		CITY:			CHANGPING DISTRICT BEIJING
		STATE:			F4
		ZIP:			102206
		BUSINESS PHONE:		858-847-9000

	MAIL ADDRESS:	
		STREET 1:		NO. 21 SHENG MING YUAN ROAD
		CITY:			CHANGPING DISTRICT BEIJING
		STATE:			F4
		ZIP:			102206
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>v460155_6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 18pt"><B>UNITED
STATES</B></FONT><BR>
<FONT STYLE="font-size: 18pt"><B>SECURITIES AND EXCHANGE COMMISSION</B></FONT><BR>
<FONT STYLE="font-size: 12pt"><B>WASHINGTON, D.C. 20549</B></FONT><BR>
<BR>
<FONT STYLE="font-size: 18pt"><B>FORM 6-K</B></FONT><BR>
<BR>
<FONT STYLE="font-size: 10pt"><B>REPORT OF FOREIGN PRIVATE ISSUER</B></FONT><BR>
<FONT STYLE="font-size: 10pt"><B>PURSUANT TO RULE 13a-16 OR 15d-16 OF</B></FONT><BR>
<FONT STYLE="font-size: 10pt"><B>THE SECURITIES EXCHANGE ACT OF 1934</B></FONT><BR>
<BR>
<FONT STYLE="font-size: 10pt"><B>FOR THE MONTH OF FEBRUARY 2017</B></FONT><BR>
<FONT STYLE="font-size: 10pt"><B>COMMISSION FILE NUMBER <U>000-51576</U></B></FONT><BR>
<BR>
<FONT STYLE="font-size: 18pt"><B>ORIGIN AGRITECH LIMITED </B></FONT><BR>
<FONT STYLE="font-size: 10pt">(Translation of registrant's name into English)</FONT><BR>
<BR>
<FONT STYLE="font-size: 10pt"><B>No. 21 Sheng Ming Yuan Road, Changping District, Beijing 102206</B></FONT><BR>
<FONT STYLE="font-size: 10pt">(Address of principal executive office)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Form 20-F <FONT STYLE="font-family: Wingdings">&#120;</FONT> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form
40-F <FONT STYLE="font-family: Wingdings">&#168;</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Indicate by check mark whether the registrant
by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule
12g3-2(b) under the Securities Exchange Act of 1934.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Yes <FONT STYLE="font-family: Wingdings">&#168;</FONT> &nbsp;&nbsp;&nbsp;No
<FONT STYLE="font-family: Wingdings">&#120;</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">If &quot;Yes&quot; is marked, indicate below
the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-________.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;&nbsp;</P>




<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 2.8pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>ORIGIN AGRITECH LIMITED</B></FONT></TD></TR>
<TR>
    <TD STYLE="width: 50%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 45%; padding-right: 0.8pt; text-align: left">&nbsp;</TD></TR>
<TR>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 0.8pt; text-align: left"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 0.8pt; text-align: left; border-bottom: Black 1pt solid">/s/ William S. Niebur</TD></TR>
<TR>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 0.8pt; text-align: left"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 0.8pt; text-align: left; border-bottom: Black 1pt solid">William S. Niebur</TD></TR>
<TR>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 0.8pt; text-align: left"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 0.8pt; text-align: left"><FONT STYLE="font-size: 10pt">Chief Executive
    Officer</FONT></TD></TR>
<TR>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 0.8pt; text-align: left">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: left">Date: February 22, 2017</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: left"></P></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 12%; border-bottom: black 1pt solid; padding-right: 0.8pt; text-align: left"><FONT STYLE="font-size: 10pt">Exhibit Number</FONT></TD>
    <TD STYLE="width: 4%; padding-right: -0.45pt; padding-left: 0.75pt; text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 84%; border-bottom: black 1pt solid; padding-right: 0.8pt; text-align: left"><FONT STYLE="font-size: 10pt">Description</FONT></TD></TR>
<TR>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="padding-right: -0.45pt; padding-left: 0.75pt; text-align: left">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 0.8pt; text-align: left"><FONT STYLE="font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: left">Press Release dated February 22,
        2017, relating to agreement with Arcadia Biosciences, Inc.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: left"></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>v460155_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B>&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt; font-size: 10pt">&nbsp;<IMG SRC="image_001.jpg" ALT="" STYLE="height: 91px; width: 115px"></TD>
    <TD ROWSPAN="2" STYLE="width: 50%; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt; font-size: 10pt; text-align: right">&nbsp;<IMG SRC="image_002.jpg" ALT=""></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt; font-size: 10pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><I>Agricultural solutions for today&rsquo;s
growing world </I></P>


</TD></TR>
</TABLE>


<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">FOR IMMEDIATE RELEASE&#9;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 9%; padding: 0; text-align: left; font-weight: bold; text-underline-color: black; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Contacts: </FONT></TD>
    <TD STYLE="width: 21%; padding: 0; text-align: left; font-weight: bold; text-underline-color: black; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Origin Agritech, Ltd.</FONT></TD>
    <TD STYLE="width: 70%; padding: 0; text-align: left; font-weight: bold; text-underline-color: black; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Arcadia Biosciences, Inc.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; font-weight: bold; text-underline-color: black; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; font-weight: bold; text-underline-color: black; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Jeff Patch</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; font-weight: bold; text-underline-color: black; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Jeff Bergau</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; font-weight: bold; text-underline-color: black; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; font-weight: bold; text-underline-color: black; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(515) 226-0818</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; font-weight: bold; text-underline-color: black; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(312) 217-0419</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; font-weight: bold; text-underline-color: black; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; font-weight: bold; text-underline-color: black; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">jpatch@thinkwixted.com</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; font-weight: bold; text-underline-color: black; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">jeff.bergau@arcadiabio.com</FONT></TD></TR>
</TABLE>


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ORIGIN, ARCADIA ANNOUNCE CHINA BIOTECHNOLOGY
COLLABORATION IN CORN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Insect resistant corn seed trait targeted
at an estimated $1 billion market</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>February 22, 2017</B>&mdash;DES MOINES and DAVIS, Calif.&mdash;Origin
(Origin Agritech, LLC, a subsidiary of Origin Agritech Ltd., NASDAQ: SEED), an agricultural biotechnology trait and seed provider,
and Arcadia (Arcadia Biosciences, Inc., NASDAQ: RKDA), a California-based company that develops and commercializes agricultural
productivity traits and nutritional products, today announced their collaboration to achieve the first-ever export of a key corn
biotechnology product developed in China to the United States for completion of global regulatory trials.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The successful movement of this corn seed, containing an insect
resistance/herbicide tolerance trait discovered and developed in China, to the Arcadia greenhouse represents a key milestone in
Origin&rsquo;s strategic business plan to achieve global regulatory approvals for cultivation and international grain movement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;This first-of-its-kind export validates&nbsp;Origin&rsquo;s
leading position in China biotech and its close alignment with Chinese ministries leading the transformation of the domestic seed
industry. Combining Origin&rsquo;s robust pipeline of value-added Chinese traits and elite corn germplasm with Arcadia&rsquo;s
research and development infrastructure&nbsp;demonstrates our plan to capture a sizeable piece of China&rsquo;s estimated billion-dollar
corn seed trait market,&rdquo; said Bill Niebur, Origin chief executive officer. &ldquo;As a leader in agtech focused on modernizing
the traditional corn seed market, our international team remains&nbsp;focused on accelerating research and development to improve
the lives of Chinese farmers.&rdquo;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Arcadia and Origin signed an agreement under which Arcadia will
assist Origin in developing information for submission to regulatory authorities in the U.S., China and other countries for the
approval of their traits in corn. This project involves production of inbred and hybrid seed lines under quarantine conditions
in Arcadia greenhouses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;Arcadia has the proven expertise to bring traits through
the regulatory process successfully and efficiently,&rdquo; said Raj Ketkar, Arcadia&rsquo;s president and CEO. &ldquo;We have
conducted hundreds of studies in the laboratory, greenhouse and field to gain regulatory approvals for various traits in major
crops, and we have a strong regulatory team that has developed complete regulatory dossiers in multiple countries. This collaboration
with Origin is an example of how our partners can leverage these capabilities to accelerate the commercialization of novel ag biotech
traits.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;Ultimately, this milestone achievement will create more
choices and opportunities for farmers,&rdquo; said Jihong Liang, Origin chief technology officer. &ldquo;This is an important achievement,
showcasing Origin&rsquo;s competitive advantage in science and global reach through collaborations inside China and beyond its
borders. Origin is leading the way in gaining regulatory approvals for this critical advanced technology globally to drive future
business growth.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Origin&rsquo;s investment and focus aligns tightly with China&rsquo;s
13<SUP>th</SUP> Five Year Plan, which calls for the modernization of agriculture as the foundation for building a prosperous society.
The Chinese government, including the Ministry of Agriculture (MOA) and Chinese Academy of Agricultural Sciences (CAAS), has advanced
a policy vision to facilitate seed industry innovation, improve the competitiveness of the Chinese ag tech industry and cultivate
new seed varieties for farmers around the world. Through these actions, China has shown strong commitment to advancing its ag industry
through new advances in biotechnology. Origin anticipates China commercialization of corn biotechnology at the end of this decade.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>###</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Origin Agritech Ltd. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Origin Agritech Limited, founded in 1997 and headquartered
in Zhong-Guan-Cun (ZGC) Life Science Park in Beijing, is China&rsquo;s leading agricultural biotechnology company, specializing
in crop seed breeding and genetic improvement, seed production, processing, distribution, and related technical services. Leading
the development of crop seed biotechnologies, Origin Agritech&rsquo;s phytase corn was the first transgenic corn to receive the
Bio-Safety Certificate from China's Ministry of Agriculture. Over the years, Origin has established a robust biotechnology seed
pipeline including products with glyphosate tolerance and pest resistance (Bt) traits. Origin operates production centers, processing
centers and breeding stations nationwide with sales centers located in key crop-planting regions. Product lines are vertically
integrated for corn, rice and canola seeds. For further information, please visit the Company&rsquo;s website at: http://www.originseed.com.cn
or <U>http://www.originseed.com.cn/en/</U>.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I></I></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Arcadia Biosciences, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Based in Davis, Calif., Arcadia Biosciences (Nasdaq: RKDA)
develops agricultural products that create added value for farmers while benefitting the environment and enhancing human health.
Arcadia&rsquo;s agronomic performance traits, including Nitrogen Use Efficiency, Water Use Efficiency, Salinity Tolerance, Heat
Tolerance and Herbicide Tolerance, are all aimed at making agricultural production more economically efficient and environmentally
sound. Arcadia&rsquo;s nutrition traits and products are aimed at creating healthier ingredients and whole foods with lower production
costs. For more information, visit www.arcadiabio.com.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This communication contains &ldquo;forward-looking statements&rdquo;
within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future
business and financial performance and financial condition, and often contain words such as &ldquo;expect,&rdquo; &ldquo;anticipate,&rdquo;
&ldquo;intend,&rdquo; &ldquo;plan,&rdquo; &ldquo;believe,&rdquo; &ldquo;seek,&rdquo; &ldquo;see,&rdquo; &ldquo;will,&rdquo; &ldquo;would,&rdquo;
&ldquo;target,&rdquo; similar expressions, and variations or negatives of these words. Forward-looking statements by their nature
address matters that are, to different degrees, uncertain, such as statements about the consummation of the proposed transaction
and the anticipated benefits thereof. Forward-looking statements are not guarantees of future performance and are based on certain
assumptions and expectations of future events which may not be realized. Forward-looking statements also involve risks and uncertainties,
many of which are beyond the company&rsquo;s control. Some of the important factors that could cause the company&rsquo;s actual
results to differ materially from those projected in any such forward-looking statements are: fluctuations in energy and raw material
prices; failure to develop and market new products and optimally manage product life cycles; ability to respond to market acceptance,
rules, regulations and policies affecting products based on biotechnology and, in general, for products for the agriculture industry;
outcome of significant litigation and environmental matters, including realization of associated indemnification assets, if any;
failure to appropriately manage process safety and product stewardship issues; changes in laws and regulations or political conditions;
global economic and capital markets conditions, such as inflation, interest and currency exchange rates; business or supply disruptions;
security threats, such as acts of sabotage, terrorism or war, natural disasters and weather events and patterns which could affect
demand as well as availability of products for the agriculture industry; ability to protect and enforce the company's intellectual
property rights; and successful integration of acquired businesses and separation of underperforming or non-strategic assets or
businesses. The company undertakes no duty to publicly revise or update any forward-looking statements as a result of future developments,
or new information or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>





</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !5 &L# 2(  A$! Q$!_\0
M'0   00# 0$             !@ %!P@! PD$ O_$ #P0  $# P,"! 0"!P<%
M      $" P0%!A$ !R$2,0@305$4(C)A0G$)%18C8I'1%U)3<H&QP8*AX?#Q
M_\0 ' $  04! 0$             !@,$!0<( 0 "_\0 .!$  0,"! ,&!0($
M!P       0(#$0 $!1(A,09!40<B87&!D1,4,J&Q%2-"@L'1%C-RHN'P\?_:
M  P# 0 "$0,1 #\ ZIZ6EI:]7J6M;JPD9)P/OK7)DHBMJ<<6$(2,DG075ZZ[
M4UE"2I$<'A.?J^Y_IJON+>,[#A-@*?[[JOI0-SXGH/'VITQ;J?5 VI\J%T1H
MY4AH%]8X^4X _P!=-#UUS7%?NTMM#[#)TTL1W)+@:905K/8)&GJ-:4EP O.)
M9S^$ J.LY?XFX[XQ<4<*"D-]&QE _G//^;TJ7^!:VX_<WKR_M'4 <^?S_D&M
MS-US6U#S VZ/N,:<!9K>.9*\_P"4:\TFT'D ^2\ES[*&#_/3G]%[3,/'QTNN
M*\ X%?[23/L:Y\2S7I'VIQA71%DK"'06%GCYCP?]=/3:TN %)!21W&HYE0GH
M*RE]M2#Z9['\CKVTBMOTM82<N,>J">WY:(^'NU6[M+GY#B=K*1IF RD?ZD]/
M$1Y4B[8I*<[)H\7])'?4%[KV[,DW[#G3Z-)K=&PPE"6H9FMI:25>>R&@E70X
MLE!#A !2.GJ21J;(TEN:REQM?4A0X(UN+*#C*1QK3K3J'T!UHRDB01L0=B*A
MB"#!H8VV@5&EV;2XM42XW+;;5^Z>=\UQILK46VUKR>I2$%"2<G)2>3W)7KY"
M #VU]:5KE+6M2\9.MFFVMS/@J>\X/JQA/YG3&^NV["U<NWC"4)*CY 37VA)4
MH)'.AFXZN9TDLH/[ELXX[*5[Z\-,ISM2D>6WP!RI7L/ZZ\G/))S_ ,Z.Z%3A
M @H21\ZQU+/WUC#AO#+CM(XB=O<1/[2>\KRGNH'AI["B%Y8LV0E&];H-.8I[
M(2RG!')5ZG\]>LD8_P!^-,UXW53;'M:JUZKO_"TVG1ER9#OLE(R<>Y/8#U)
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73C';2TM3%H(: HALD!#, G<[DG\U_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !L )H# 2(  A$! Q$!_\0
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
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
